Wound Care Biologics Industry Research Report 2024

Wound Care Biologics Industry Research Report 2024


Summary

Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.
Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
According to APO Research, The global Wound Care Biologics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Wound Care Biologics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Wound Care Biologics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Wound Care Biologics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Wound Care Biologics include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, Derma Sciences, Inc, Soluble Systems, Amnio Technology, LLC and Medline, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Wound Care Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wound Care Biologics.
The Wound Care Biologics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Wound Care Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Smith and Nephew
Organogenesis
MiMedx
Integra
Osiris
Derma Sciences, Inc
Soluble Systems
Amnio Technology, LLC
Medline
Skye® Biologics
Alphatec Spine,Inc.
Pinnacle Transplant Technologies
Wound Care Biologics segment by Type

Biologic Skin Substitutes
Enzyme Based Formulations
Growth Factors
Wound Care Biologics Segment by Application

Acute Wounds
Chronic Wounds
Surgical Wounds
Wound Care Biologics Segment by Region

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wound Care Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Wound Care Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wound Care Biologics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Wound Care Biologics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Wound Care Biologics by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Biologic Skin Substitutes
2.2.3 Enzyme Based Formulations
2.2.4 Growth Factors
2.3 Wound Care Biologics by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Acute Wounds
2.3.3 Chronic Wounds
2.3.4 Surgical Wounds
2.4 Assumptions and Limitations
3 Wound Care Biologics Breakdown Data by Type
3.1 Global Wound Care Biologics Historic Market Size by Type (2019-2024)
3.2 Global Wound Care Biologics Forecasted Market Size by Type (2025-2030)
4 Wound Care Biologics Breakdown Data by Application
4.1 Global Wound Care Biologics Historic Market Size by Application (2019-2024)
4.2 Global Wound Care Biologics Forecasted Market Size by Application (2019-2024)
5 Global Growth Trends
5.1 Global Wound Care Biologics Market Perspective (2019-2030)
5.2 Global Wound Care Biologics Growth Trends by Region
5.2.1 Global Wound Care Biologics Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Wound Care Biologics Historic Market Size by Region (2019-2024)
5.2.3 Wound Care Biologics Forecasted Market Size by Region (2025-2030)
5.3 Wound Care Biologics Market Dynamics
5.3.1 Wound Care Biologics Industry Trends
5.3.2 Wound Care Biologics Market Drivers
5.3.3 Wound Care Biologics Market Challenges
5.3.4 Wound Care Biologics Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Wound Care Biologics Players by Revenue
6.1.1 Global Top Wound Care Biologics Players by Revenue (2019-2024)
6.1.2 Global Wound Care Biologics Revenue Market Share by Players (2019-2024)
6.2 Global Wound Care Biologics Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Wound Care Biologics Head office and Area Served
6.4 Global Wound Care Biologics Players, Product Type & Application
6.5 Global Wound Care Biologics Players, Date of Enter into This Industry
6.6 Global Wound Care Biologics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Wound Care Biologics Market Size (2019-2030)
7.2 North America Wound Care Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Wound Care Biologics Market Size by Country (2019-2024)
7.4 North America Wound Care Biologics Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Wound Care Biologics Market Size (2019-2030)
8.2 Europe Wound Care Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Wound Care Biologics Market Size by Country (2019-2024)
8.4 Europe Wound Care Biologics Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Wound Care Biologics Market Size (2019-2030)
9.2 Asia-Pacific Wound Care Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Wound Care Biologics Market Size by Country (2019-2024)
9.4 Asia-Pacific Wound Care Biologics Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 Latin America
10.1 Latin America Wound Care Biologics Market Size (2019-2030)
10.2 Latin America Wound Care Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Wound Care Biologics Market Size by Country (2019-2024)
10.4 Latin America Wound Care Biologics Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Wound Care Biologics Market Size (2019-2030)
11.2 Middle East & Africa Wound Care Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Wound Care Biologics Market Size by Country (2019-2024)
11.4 Middle East & Africa Wound Care Biologics Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 Players Profiled
12.1 Smith and Nephew
12.1.1 Smith and Nephew Company Information
12.1.2 Smith and Nephew Business Overview
12.1.3 Smith and Nephew Revenue in Wound Care Biologics Business (2019-2024)
12.1.4 Smith and Nephew Wound Care Biologics Product Portfolio
12.1.5 Smith and Nephew Recent Developments
12.2 Organogenesis
12.2.1 Organogenesis Company Information
12.2.2 Organogenesis Business Overview
12.2.3 Organogenesis Revenue in Wound Care Biologics Business (2019-2024)
12.2.4 Organogenesis Wound Care Biologics Product Portfolio
12.2.5 Organogenesis Recent Developments
12.3 MiMedx
12.3.1 MiMedx Company Information
12.3.2 MiMedx Business Overview
12.3.3 MiMedx Revenue in Wound Care Biologics Business (2019-2024)
12.3.4 MiMedx Wound Care Biologics Product Portfolio
12.3.5 MiMedx Recent Developments
12.4 Integra
12.4.1 Integra Company Information
12.4.2 Integra Business Overview
12.4.3 Integra Revenue in Wound Care Biologics Business (2019-2024)
12.4.4 Integra Wound Care Biologics Product Portfolio
12.4.5 Integra Recent Developments
12.5 Osiris
12.5.1 Osiris Company Information
12.5.2 Osiris Business Overview
12.5.3 Osiris Revenue in Wound Care Biologics Business (2019-2024)
12.5.4 Osiris Wound Care Biologics Product Portfolio
12.5.5 Osiris Recent Developments
12.6 Derma Sciences, Inc
12.6.1 Derma Sciences, Inc Company Information
12.6.2 Derma Sciences, Inc Business Overview
12.6.3 Derma Sciences, Inc Revenue in Wound Care Biologics Business (2019-2024)
12.6.4 Derma Sciences, Inc Wound Care Biologics Product Portfolio
12.6.5 Derma Sciences, Inc Recent Developments
12.7 Soluble Systems
12.7.1 Soluble Systems Company Information
12.7.2 Soluble Systems Business Overview
12.7.3 Soluble Systems Revenue in Wound Care Biologics Business (2019-2024)
12.7.4 Soluble Systems Wound Care Biologics Product Portfolio
12.7.5 Soluble Systems Recent Developments
12.8 Amnio Technology, LLC
12.8.1 Amnio Technology, LLC Company Information
12.8.2 Amnio Technology, LLC Business Overview
12.8.3 Amnio Technology, LLC Revenue in Wound Care Biologics Business (2019-2024)
12.8.4 Amnio Technology, LLC Wound Care Biologics Product Portfolio
12.8.5 Amnio Technology, LLC Recent Developments
12.9 Medline
12.9.1 Medline Company Information
12.9.2 Medline Business Overview
12.9.3 Medline Revenue in Wound Care Biologics Business (2019-2024)
12.9.4 Medline Wound Care Biologics Product Portfolio
12.9.5 Medline Recent Developments
12.10 Skye® Biologics
12.10.1 Skye® Biologics Company Information
12.10.2 Skye® Biologics Business Overview
12.10.3 Skye® Biologics Revenue in Wound Care Biologics Business (2019-2024)
12.10.4 Skye® Biologics Wound Care Biologics Product Portfolio
12.10.5 Skye® Biologics Recent Developments
12.11 Alphatec Spine,Inc.
12.11.1 Alphatec Spine,Inc. Company Information
12.11.2 Alphatec Spine,Inc. Business Overview
12.11.3 Alphatec Spine,Inc. Revenue in Wound Care Biologics Business (2019-2024)
12.11.4 Alphatec Spine,Inc. Wound Care Biologics Product Portfolio
12.11.5 Alphatec Spine,Inc. Recent Developments
12.12 Pinnacle Transplant Technologies
12.12.1 Pinnacle Transplant Technologies Company Information
12.12.2 Pinnacle Transplant Technologies Business Overview
12.12.3 Pinnacle Transplant Technologies Revenue in Wound Care Biologics Business (2019-2024)
12.12.4 Pinnacle Transplant Technologies Wound Care Biologics Product Portfolio
12.12.5 Pinnacle Transplant Technologies Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings